Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Phase 1 Recruiting
40 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
ADVICE
Phase 1/2 Recruiting
80 enrolled
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
Phase 1 Recruiting
25 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Phase 2 Recruiting
50 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Dabrafenib and/or Trametinib Rollover Study
Phase 4 Recruiting
100 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
iCaRe2
Recruiting
999,999 enrolled
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Phase 3 Recruiting
269 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Recruiting
500 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/2 Recruiting
754 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
CAPTIV-8
Phase 2 Recruiting
200 enrolled
TraveraRTGx
Recruiting
200 enrolled
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Phase 1 Recruiting
15 enrolled
Agni-01
Phase 1/2 Recruiting
52 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
DOPACER
Phase NA Recruiting
52 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
Adaptive Symptom Self-Management Immunotherapy Study
Phase NA Recruiting
400 enrolled
LONGEVITI
Recruiting
75 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
MOHCCN-O
Recruiting
500 enrolled
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Phase 1/2 Recruiting
53 enrolled
OCTANE
Recruiting
10,000 enrolled
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 Recruiting
134 enrolled
MONITOR
Phase NA Recruiting
100 enrolled
SkinHealth
Recruiting
420 enrolled
Telenursing
Phase NA Recruiting
40 enrolled
CER
Recruiting
15,000 enrolled
POSITive
Recruiting
265 enrolled
NТО-RAS
Phase 2 Recruiting
20 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled